Case of catastrophic antiphospholipid syndrome presenting as neuroretinitis and vaso-occlusive retinopathy

BMC Ophthalmol. 2020 Dec 9;20(1):482. doi: 10.1186/s12886-020-01755-9.

Abstract

Background: Ocular involvement in catastrophic antiphospholipid syndrome (CAPS), a rare, life-threatening form of antiphospholipid syndrome (APS) that results in multiorgan failure and a high mortality rate, has rarely been reported.

Case presentation: A 15-year-old girl presented with sudden vision blurring in both eyes. She had marked optic disc swelling and macular exudates in the right eye and intra-arterial white plaques, a few retinal blot hemorrhages, and a white ischemic retina in the left eye. Systemic examination revealed she had acute kidney injury with thrombotic microangiopathy (TMA), multiple cerebral infarcts, valvular dysfunction, and a high titer of triple aPL. Thus, she was diagnosed with CAPS involving the brain, eyes, heart, and kidneys. Plasma exchange and the administration of glucocorticoids, immunoglobulin, warfarin, and rituximab brought a sustained recovery of the TMA, visual symptoms, and echocardiographic findings.

Conclusions: Ocular involvement of both vaso-occlusive retinopathy, an APS-related thrombotic microangiopathy, and neuroretinitis, a non-thrombotic microangiopathy, can occur as an initial presentation of CAPS.

Keywords: Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Neuroretinitis; Thrombotic microangiopathy; Vaso-occlusive retinopathy.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antiphospholipid Syndrome* / complications
  • Antiphospholipid Syndrome* / diagnosis
  • Chorioretinitis*
  • Female
  • Glucocorticoids
  • Humans
  • Retinitis* / diagnosis
  • Retinitis* / etiology
  • Rituximab

Substances

  • Glucocorticoids
  • Rituximab